Multisystemic BCGitis: A rare complication of intravesical BCG immunotherapy for bladder cancer

Intermediate- to high-grade non-muscle invasive bladder cancer is preferably treated with transurethral resection followed by adjuvant intravesical immunotherapy with Bacillus Calmette-Guérin (BCG). BCG acts as an immune stimulator, inducing a complex inflammatory response that selectively targets t...

Descripción completa

Detalles Bibliográficos
Autores principales: Vilares, Ana T., Nunes Silva, Cláudio, Correia da Silva, Miguel, Sousa, Joel, Viamonte, Bárbara, Madureira, António J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096469/
https://www.ncbi.nlm.nih.gov/pubmed/35570860
http://dx.doi.org/10.1016/j.radcr.2022.04.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096469/
https://www.ncbi.nlm.nih.gov/pubmed/35570860
http://dx.doi.org/10.1016/j.radcr.2022.04.022

Ejemplares similares